NFE2L2 and cancer: NFE2L2 (also known as NRF2) responds to oxidative stress to help prevent cancerous transformation of normal cells but is often up-regulated in established cancers and, thus, can be described as a double-edged sword (Jenkins and Gouge, 2021).